Cyclacel Pharma (CYCC) Reports Q1 Loss of $0.38
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Foreign exchange (losses)/gains: 51K
Today's EPS Names:
CRMT, PKE, More
Financial Fact:
Foreign exchange (losses)/gains: 51K
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.38), versus ($0.12) reported last year.
As of March 31, 2018, cash and cash equivalents totaled $21.7 million, compared to $23.9 million as of December 31, 2017. The decrease of $2.2 million was primarily due to net cash used in operating activities.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- TD Cowen Upgrades Flagstar Bank (FLG) to Buy
- Lucid reports Q2 output, names new CFO and five other leaders
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
